TELA Bio (TELA) EBIT Growth (3y) (2021 - 2026)
TELA Bio (TELA) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | 2.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20% |
| Dec 31, 2025 | 11.03% |
| Sep 30, 2025 | 7.31% |
| Jun 30, 2025 | 3.92% |
| Mar 31, 2025 | -2.08% |
| Dec 31, 2024 | -2.96% |
| Sep 30, 2024 | -9.07% |
| Jun 30, 2024 | -16.53% |
| Mar 31, 2024 | 12.76% |
| Dec 31, 2023 | -22.09% |
| Sep 30, 2023 | -14.05% |
| Jun 30, 2023 | -26.11% |
| Mar 31, 2023 | -20.08% |
| Dec 31, 2022 | -17.45% |
| Sep 30, 2022 | -35.00% |
| Jun 30, 2022 | -33.53% |
| Mar 31, 2022 | -23.86% |
| Dec 31, 2021 | -11.66% |
| Sep 30, 2021 | -41.93% |